Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series.

Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio

Martora, Fabrizio; Fabbrocini, Gabriella; Marasca, Claudio.

Martora F; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fabbrocini G; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Marasca C; Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Dermatol Ther ; 35(2): e15225, 2022 02.

Article in English | MEDLINE | ID: covidwho-1529870

Subject(s)

Pityriasis Rosea; Vaccines; 2019-nCoV Vaccine mRNA-1273; Humans; Pityriasis Rosea/diagnosis; Pityriasis Rosea/etiology; Skin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Pityriasis Rosea Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15225

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google